Calgary’s Kent Imaging has developed a cutting-edge handheld imaging device that’s making waves in the digital health industry. This innovative tool assesses blood oxygen levels using light wavelengths, a revolutionary approach that eliminates the need for traditional X-rays or ultrasounds. Before Snapshot N-I-R, no device could measure oxygen levels in this manner, making Kent Imaging a true trailblazer in the field. The device is transforming surgical and chronic wound practices, providing unprecedented insights for practitioners and patients alike. Kent Imaging CEO Pierre Lemire highlights the importance of oxygen assessment in wound healing, stating, “If you have a wound that’s not healing, you want to find out why. The first thing you check is, does it have enough oxygen?” Kent Imaging’s partnership with Alberta Innovates has spanned over a decade, with the latter providing invaluable support as the company grew from its humble beginnings to its current success. Bindi Ferguson, Director of Commercialization for Alberta Innovates, praises Kent Imaging’s impact on patient outcomes, emphasizing that their product is “improving patients’ outcomes with a product that was researched, developed, and built right here in Calgary.” The Snapshot N-I-R is primarily used in the United States, with increasing adoption in Canada and Australia. It awaits approval for use in the European market, further expanding its reach and potential to enhance healthcare worldwide.
Calgary-Based Company Develops Handheld Imaging Device Revolutionizing Digital Health
